Hemophilia Clinical Trial Patient Recruitment

Hemophilia A and B patient recruitment for factor replacement, gene therapy, and non-factor therapy clinical trials.

Who qualifies: Males with severe or moderate hemophilia A or B (factor activity <5%), with or without inhibitors.

Recruitment challenges: Factor activity level requirements and inhibitor status eligibility criteria.

Our approach: Hemophilia treatment center networks, NHF chapter partnerships, and factor activity pre-screening.